O TYM ODCINKU
Guest: Andrew Mastro, MS, PA-C
In atopic dermatitis, the timing of itch relief and visible skin improvement can make all the difference in how patients perceive their response to topical JAK inhibitor therapy. Andrew Mastro, physician assistant at the Illinois Dermatology Institute and DeNova Research in Chicago, shares his approach to translating clinical trial data into practical counseling strategies, setting meaningful treatment milestones, and timing follow-up visits to capture early wins and address emerging challenges.
Język angielski
Stany Zjednoczone
W TYM ODCINKU
TRANSKRYPCJA 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
WYSZUKAJ MINIONE ODCINKI
Wyszukaj minione odcinki DermConsult.
INNE ODCINKI W TYM PODCASCIE
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Christina Kraus, MD
Guest: Jill Krapf, MD
Vulvar lichen sclerosus sits at the intersection of dermatology and gynecology, making coordinated care essential. In this expert-led conversation, Dr. Charles Turck sits down with Dr. Chris…
Host: Alexandria May, PharmD, BCPS
Guest: Naiem T. Issa, MD, PhD, FAAD
Guest: Allison Truong, MD
Atopic dermatitis affecting the face, neck, hands, genital, and intertriginous areas can have a profound impact on patients' quality of life, even when overall disease involvement app…
Host: Alexandria May, PharmD, BCPS
Guest: Naiem T. Issa, MD, PhD, FAAD
Inflammatory dermatoses don't always follow the rules. When clinical features overlap or presentations fall outside familiar patterns, reaching the right diagnosis requires a thoughtful, systematic approach. In th…
Host: Shelina Ramnarine, PhD
Guest: Christopher Bunick, MD, PhD, FAAD
Hand atopic dermatitis and other subtypes of chronic hand eczema can present similarly, but differences in their underlying drivers can have important implications for diagnosis and treatment. Review which clinical…
Guest: Peter Lio, MD
Atopic dermatitis may look similar across patients, but could distinct underlying mechanisms call for more personalized treatment approaches? Dr. Peter Lio explores how emerging biomarkers could help us better understand individual disease drivers, …
Zastrzeżenie: Podcast i grafika osadzone na tej stronie pochodzą z ReachMD, który jest własnością jego właściciela i nie jest powiązany ani wspierany przez Listen Notes, Inc.
EDYTUJ
Dziękujemy za pomoc w aktualizowaniu podcastowej bazy danych.